糖宁通络片联合糖宁通络乳膏对2型糖尿病足溃疡的临床疗效与安全性研究

胡人月, 孙琦, 顾海云, 潘玉杰, 周冉冉, 施荣峰, 梁光武, 许彤彤, 陈靖, 孙田甜, 唐祝奇, 夏文, 顾云娟

湖南师范大学学报医学版 ›› 2025, Vol. 22 ›› Issue (3) : 82-88.

PDF(1942 KB)
PDF(1942 KB)
湖南师范大学学报医学版 ›› 2025, Vol. 22 ›› Issue (3) : 82-88.
临床医学

糖宁通络片联合糖宁通络乳膏对2型糖尿病足溃疡的临床疗效与安全性研究

  • 胡人月1, 孙琦1, 顾海云1, 潘玉杰2, 周冉冉1, 施荣峰1, 梁光武2, 许彤彤1, 陈靖1, 孙田甜2, 唐祝奇1, 夏文2, 顾云娟1
作者信息 +

Clinical efficacy and safety of Tangning Tongluo tablets combined with Tangning Tongluo cream in the treatment of type 2 diabetic foot ulcer

  • HU Renyue1, SUN Qi1, GU Haiyun1, PAN Yujie2, ZHOU Ranran1, SHI Rongfeng1, LIANG Guangwu2, XU Tongtong1, CHEN Jing1, SUN Tiantian2, TANG Zhuqi1, XIA Wen2, GU Yunjuan1
Author information +
文章历史 +

摘要

目的: 评估糖宁通络片及糖宁通络乳膏对2型糖尿病足溃疡患者的临床疗效及安全性。方法: 纳入100例糖尿病足患者,随机分为5组,对照组(常规治疗)、口服组(常规治疗+糖宁通络片)、外敷组(常规治疗+糖宁通络膏)及联合组(常规+糖宁通络片+糖宁通络膏)、大剂量口服组(常规治疗+糖宁通络片大剂量口服),最终剔除5例,实际分析病例为95例,收集并比较各组患者基线特征,比较观察患者治疗1个月和3个月的结局、血清学指标变化以及Wagner分级<4级或Wagner分级=4级的溃疡结局并记录整个治疗期间的不良反应。结果: 患者各组间基线资料比较无显著性差异。治疗后1个月,总体人群和Wagner分级<4级患者的愈合率差异不显著;治疗后3个月时,总体人群和Wagner分级<4级患者的愈合率存在显著差异,口服组、外敷组、联合组和大剂量口服组的愈合率均显著高于对照组。治疗后3个月,大剂量口服组白细胞水平显著降低;除对照组外,其余各组中性粒细胞计数均明显下降,各组谷丙转氨酶、谷草转氨酶、白蛋白及肌酐水平治疗前后无显著变化。在整个治疗过程中患者均未出现任何不良反应。结论: 联合使用糖宁通络片与糖宁通络乳膏,可以有效减轻创面感染并促进创面愈合,其长期临床疗效显著高于常规治疗,且安全性良好,改善了患者的临床预后,具有较高的临床应用价值。

Abstract

Objective To evaluate the clinical efficacy and safety of Tangning Tongluo tablets and Tangning Tongluo cream in patients with type 2 diabetic foot ulcer. Methods 100 patients with diabetic foot were randomly divided into 5 groups: control group (routine treatment), oral group (routine treatment+Tangning Tongluo tablet), external application group (routine treatment+Tangning Tongluo ointment), combined group (routine treatment+Tangning Tongluo tablet+Tangning Tongluo ointment) and high-dose oral group (routine treatment+Tangning Tongluo tablet). Finally, 5 cases were excluded. The outcomes of patients treated for 1 month and 3 months, the changes of serological indexes, and the ulcer outcomes with Wagner grade<4 or Wagner grade=4 were compared and observed, and the adverse reactions during the whole treatment period were recorded. Results There was no significant difference in baseline data between the groups. One month after treatment, there was no significant difference in the healing rate between the general population and patients with Wagner grade<4. Three months after treatment, there were significant differences in the healing rate between the general population and patients with Wagner grade<4, and the healing rates of oral group, external application group, combined group and high-dose oral group were significantly higher than those of the control group. Serological indicators, 3 months after treatment, the level of white blood cells in the high-dose oral group decreased significantly; Except for the control group, the neutrophil count in other groups decreased significantly, and the levels of alanine aminotransferase, aspartate aminotransferase, albumin and creatinine in each group did not change significantly before and after treatment. Safety evaluation showed that the patients did not have any adverse reactions during the whole treatment. Conclusion The combined use of Tangning Tongluo Tablet and Tangning Tongluo Cream can effectively reduce wound infection and promote wound healing. Its long-term clinical efficacy is significantly higher than that of conventional treatment, and its safety is good, which improves the clinical prognosis of patients and has high clinical application value.

关键词

糖宁通络 / 糖尿病足溃疡 / 2型糖尿病

Key words

Tangning Tongluo / diabetic foot ulcer / type 2 diabetes

引用本文

导出引用
胡人月, 孙琦, 顾海云, 潘玉杰, 周冉冉, 施荣峰, 梁光武, 许彤彤, 陈靖, 孙田甜, 唐祝奇, 夏文, 顾云娟. 糖宁通络片联合糖宁通络乳膏对2型糖尿病足溃疡的临床疗效与安全性研究[J]. 湖南师范大学学报医学版. 2025, 22(3): 82-88
HU Renyue, SUN Qi, GU Haiyun, PAN Yujie, ZHOU Ranran, SHI Rongfeng, LIANG Guangwu, XU Tongtong, CHEN Jing, SUN Tiantian, TANG Zhuqi, XIA Wen, GU Yunjuan. Clinical efficacy and safety of Tangning Tongluo tablets combined with Tangning Tongluo cream in the treatment of type 2 diabetic foot ulcer[J]. Journal of Hunan Normal University(Medical Science). 2025, 22(3): 82-88
中图分类号: R587.1   

参考文献

[1] ZHANG P, LU J, JING Y, et al. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis[J]. Ann Med, 2017 Mar, 49(2): 106-116.
[2] NDOSI M, WRIGHT-HUGHES A, BROWN S, et al. Prognosis of the infected diabetic foot ulcer: a 12-month prospective observational study[J]. Diabet Med, 2018 Jan, 35(1): 78-88.
[3] SCHAPER NC, VAN NETTEN JJ, APELQVIST J, et al.Practical guidelines on the prevention and management of diabetes-related foot disease (IWGDF 2023 update)[J]. Diabetes Metab Res Rev, 2024, 40(3): e3657.
[4] 朱信霖, 扈东营, 陈显振, 等. 糖尿病足溃疡发病机制及治疗相关研究进展[J/OL]. 中国皮肤性病学杂志, 1-12[2025-09-22]. https://link.cnki.net/urlid/61.1197.R.20221202.1306.003.
[5] DURANDO P, FERREIRA A, CELIS ME.Acute administration of alpha-melanotropin exerts a stimulatory control on puberty[J]. Acta Endocrinol (Copenh), 1989, 120(5): 661-666.
[6] 金德, 连凤梅, 仝小林. 糖宁通络胶囊“六郁”解[J]. 北京中医药, 2017, 36(06): 543-546.
[7] 卢珊, 王婷婷, 李永吉. 糖宁通络胶囊对db/db小鼠高血糖症以及视网膜肾脏病变的疗效研究[J]. 中国现代中药, 2015, 17(06): 551-555.
[8] 张富文, 段俊国, 夏文, 等. 糖宁通络片治疗非增殖期糖尿病视网膜病变的临床疗效[J]. 中国实验方剂学杂志, 2025, 31(03): 132-139.
[9] 王林华, 卢敏, 段航, 等. 胫骨横向骨搬移微创导板技术联合桃红四物汤治疗糖尿病足溃疡的疗效分析[J]. 湖南中医药大学学报, 2024, 44(09): 1646-1652.
[10] 张雪芹, 曲玮, 梁敬钰. 车前草化学成分和药理作用研究进展[J]. 海峡药学, 2013, 25(11): 1-8.
[11] 金情政, 李钦, 赵吟. 瓜蒌子油对糖尿病小鼠降血糖作用的研究[J]. 药学实践杂志, 2015, 33(04): 324-327.
[12] 庄雅舒, 王丽, 霍晶晶. 基于网络药理学探讨鸡血藤对糖尿病周围神经病变的作用机制[J]. 中医临床研究, 2021, 13(35): 10-14.
[13] 周玲玉. 金银花改善糖尿病视网膜病变药效活性及其机理[D]. 乌鲁木齐: 新疆医科大学, 2016.
[14] 陈文鹏, 卢健棋, 庞延, 等. 仙鹤草化学成分、药理作用及临床应用研究进展[J]. 辽宁中医药大学学报, 2022, 24(06): 118-122.
[15] ARMSTRONG DG, TAN TW, BOULTON AJM, et al.Diabetic Foot Ulcers: A Review[J]. JAMA, 2023, 330(1): 62-75.
[16] CHANG M, NGUYEN TT.Strategy for Treatment of Infected Diabetic Foot Ulcers[J]. Acc Chem Res, 2021, 54(5): 1080-1093.
[17] QIU Y, AI PF, SONG JJ, et al.Total Flavonoid Extract from Abelmoschus manihot (L. ) Medic Flowers Attenuates d-Galactose-Induced Oxidative Stress in Mouse Liver Through the Nrf2 Pathway[J]. J Med Food, 2017, 20(6): 557-567.
[18] 蔡曾晓瑞. 糖宁通络片对糖尿病小鼠的治疗作用及相关机制研究[D]. 锦州: 锦州医科大学, 2023.
[19] WANG N, ZHANG C, XU Y, et al.OMICs approaches-assisted identification of macrophages-derived MIP-1γ as the therapeutic target of botanical products TNTL in diabetic retinopathy[J]. Cell Commun Signal, 2019, 17(1): 81.
[20] REN Y, HU X, QI M, et al.Tangningtongluo Tablet ameliorates pancreatic damage in diabetic mice by inducing autophagy and inhibiting the PI3K/Akt/mTOR signaling pathway[J]. Int Immunopharmacol, 2024, 142(Pt A): 113032.
[21] 陈均, 杨恵. 糖宁通络胶囊治疗糖尿病足的临床经验[J]. 中国医药导报, 2016, 13(34): 89-92, 104.
[22] CHENG L, SONG J, LI G, et al.[Corrigendum] Effects of the Tangningtongluo formula as an alternative strategy for diabetics via upregulation of insulin receptor substrate-1[J]. Mol Med Rep, 2019, 20(5): 4391-4392.
[23] CHENG L, MENG XB, LU S, et al.Evaluation of hypoglycemic efficacy of tangningtongluo formula, a traditional Chinese Miao medicine, in two rodent animal models[J]. J Diabetes Res, 2014, 2014: 745419.

基金

南通市科技计划项目“糖尿病足多学科规范化诊疗”(MSZ2023155);南通市科技计划项目“氧化应激诱导脂肪干细胞外泌体综合改善创面微环境促糖尿病足溃疡愈合机制研究”(JCZ2023004);南通大学附属医院研究型医院建设经费“揭榜挂帅”——研究型学科(联合)发展基金(YJXYY202204-XKB09)

PDF(1942 KB)

Accesses

Citation

Detail

段落导航
相关文章

/